跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEQ-400
首页
药物
SEQ-400
SEQ-400
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Peptide inhibitors of ABL kinases
US 8148320 B2
申请人: KOTULA LESZEK
优先权: 2005
CN
US
4 件公开
SHIGELLA VACCINE COMPOSITIONS
EP 4798232 A1
申请人: VAXCYTE INC
优先权: 2023
CN
EP
WO
3 件公开
PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN-DOPAMINE CONJUGATES
US 2011065632 A1
申请人: DONG ZHENG XIN
优先权: 2009
CN
US
2 件公开
Ultramarine fluorescent protein, construction method therefor and use thereof in preparation of protein sunscreen agent
US 11746132 B2
申请人: UNIV ZHEJIANG NORMAL
优先权: 2020
CN
US
2 件公开
Immunoglobulin binding protein
US 6884629 B2
申请人: AFFITECH AS
优先权: 1998
US
2 件公开
Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same
US 8101736 B2
申请人: BRESLER TAL
优先权: 2006
US
2 件公开
SYNP159, a promoter for the specific expression of genes in rod photoreceptors
US 10995344 B2
申请人: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES
优先权: 2015
US
2 件公开
Thymosin beta-15 promoter and uses thereof
US 6489463 B1
申请人: CHILDRENS MEDICAL CENTER
优先权: 2000
US
Isolated polypeptide having arabinofuranosidase activity
US 7666648 B2
申请人: DANISCO US INC
优先权: 2003
US
Deletion mutant of a set of hepatitis B HBx gene and application thereof
CN 101058815 A
申请人: ZHU PINGAN
优先权: 2007
CN
第 1 / 3 页
上一页
下一页
药物
反馈